Literature DB >> 30091492

Prolyl hydroxylases positively regulated LPS-induced inflammation in human gingival fibroblasts via TLR4/MyD88-mediated AKT/NF-κB and MAPK pathways.

Lingling Shang1,2, Ting Wang1,2, Dongdong Tong3, Wenyan Kang1,2, Qianyu Liang1,2, Shaohua Ge1,2.   

Abstract

OBJECTIVES: Prolyl hydroxylases (PHDs) play essential roles in oxygen-sensing system, whereas the effects of PHDs on inflammation have not been totally uncovered. Our study aimed to investigate the role of PHDs in lipopolysaccharide (LPS)-induced inflammation of human gingival fibroblasts (HGFs) and clarify the potential mechanisms.
MATERIALS AND METHODS: A pan hydroxylase inhibitor, dimethyloxallyl glycine (DMOG), and RNA interference were used to explore the role of PHDs in inflammation. Cytotoxic effect of DMOG was determined by cell-counting kit-8 and flow cytometry respectively. The secretion levels of IL-6 and IL-8 were assessed by ELISA. The mRNA levels of inflammatory cytokines, Toll-like receptor (TLR) 4 and MyD88 were evaluated by quantitative real-time PCR. The activation of NF-κB, mitogen-activated protein kinase (MAPK) and PI3K/AKT pathways were detected by western blot and the nuclear translocation of NF-κB p65 was examined by immunofluorescence. Downregulation of PHD1 and PHD2 was performed with siRNA transfection.
RESULTS: Dimethyloxallyl glycine inhibited LPS-induced inflammatory cytokine, TLR4 and MyD88 expression in gene level and the elevated secretion of IL-6 and IL-8 was also downregulated. Additionally, LPS-induced activation of NF-κB, MAPK and AKT pathways was abolished by DMOG treatment. Importantly, LPS-induced inflammatory cytokine expression was merely suppressed by PHD2 knockdown.
CONCLUSIONS: Prolyl hydroxylases acted as a positive regulator in LPS-induced inflammation of HGFs via TLR4/MyD88-mediated NF-κB, MAPK and AKT signalling pathways and PHD2 among three isoforms was principally responsible for the effects.
© 2018 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30091492      PMCID: PMC6528886          DOI: 10.1111/cpr.12516

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  50 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Prolyl-4-hydroxylase domain protein 2 controls NF-κB/p65 transactivation and enhances the catabolic effects of inflammatory cytokines on cells of the nucleus pulposus.

Authors:  Jun Li; Wen Yuan; Shuai Jiang; Wei Ye; Hao Yang; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

3.  The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells.

Authors:  Emily Hams; Sean P Saunders; Eoin P Cummins; Aisling O'Connor; Murtaza T Tambuwala; William M Gallagher; Annette Byrne; Antonio Campos-Torres; Paul M Moynagh; Christian Jobin; Cormac T Taylor; Padraic G Fallon
Journal:  Shock       Date:  2011-09       Impact factor: 3.454

4.  Metformin Inhibits Porphyromonas gingivalis Lipopolysaccharide-Influenced Inflammatory Response in Human Gingival Fibroblasts via Regulating Activating Transcription Factor-3 Expression.

Authors:  Wenyan Kang; Ting Wang; Zhekai Hu; Feng Liu; Yundong Sun; Shaohua Ge
Journal:  J Periodontol       Date:  2017-05-26       Impact factor: 6.993

5.  Lipopolysaccharide and IL-1β coordinate a synergy on cytokine production by upregulating MyD88 expression in human gingival fibroblasts.

Authors:  Colleen W Brinson; Zhongyang Lu; Yanchun Li; Maria F Lopes-Virella; Yan Huang
Journal:  Mol Immunol       Date:  2016-09-30       Impact factor: 4.407

Review 6.  Bacterial invasion and persistence: critical events in the pathogenesis of periodontitis?

Authors:  S Ji; Y S Choi; Y Choi
Journal:  J Periodontal Res       Date:  2014-12-08       Impact factor: 4.419

Review 7.  Targeting the HIF pathway in inflammation and immunity.

Authors:  Carsten C Scholz; Cormac T Taylor
Journal:  Curr Opin Pharmacol       Date:  2013-05-07       Impact factor: 5.547

8.  Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa.

Authors:  Bettina Schaible; Siobhán McClean; Andrew Selfridge; Alexis Broquet; Karim Asehnoune; Cormac T Taylor; Kirsten Schaffer
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  MAPK usage in periodontal disease progression.

Authors:  Qiyan Li; Michael S Valerio; Keith L Kirkwood
Journal:  J Signal Transduct       Date:  2012-01-23

Review 10.  Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challenges.

Authors:  Jonathan Michael Harnoss; Moritz Johannes Strowitzki; Praveen Radhakrishnan; Lisa Katharina Platzer; Julian Camill Harnoss; Thomas Hank; Jun Cai; Alexis Ulrich; Martin Schneider
Journal:  Hypoxia (Auckl)       Date:  2015-01-30
View more
  17 in total

1.  Prolyl hydroxylases positively regulated LPS-induced inflammation in human gingival fibroblasts via TLR4/MyD88-mediated AKT/NF-κB and MAPK pathways.

Authors:  Lingling Shang; Ting Wang; Dongdong Tong; Wenyan Kang; Qianyu Liang; Shaohua Ge
Journal:  Cell Prolif       Date:  2018-08-09       Impact factor: 6.831

2.  Dimethyloxallyl glycine/nanosilicates-loaded osteogenic/angiogenic difunctional fibrous structure for functional periodontal tissue regeneration.

Authors:  Lingling Shang; Ziqi Liu; Baojin Ma; Jinlong Shao; Bing Wang; Chenxi Ma; Shaohua Ge
Journal:  Bioact Mater       Date:  2020-10-26

3.  Ethyl pyruvate inhibits LPS induced IPEC-J2 inflammation and apoptosis through p38 and ERK1/2 pathways.

Authors:  Na Dong; Xinyao Xu; Chenyu Xue; Chensi Wang; Xinran Li; Chongpeng Bi; Anshan Shan
Journal:  Cell Cycle       Date:  2019-09-01       Impact factor: 4.534

4.  MyD88 Regulates LPS-induced NF-ĸB/MAPK Cytokines and Promotes Inflammation and Malignancy in Colorectal Cancer Cells.

Authors:  Guangwei Zhu; Zhibin Cheng; Chunlin Lin; Robert M Hoffman; Yongjian Huang; Shree Ram Singh; Wei Zheng; Shugang Yang; Jianxin Ye
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

5.  Expression and Significance of MyD88 in Patients With Gastric Cardia Cancer in a High-Incidence Area of China.

Authors:  Jingyao Chen; Di Xia; Muming Xu; Ruibing Su; Wenting Lin; Dan Guo; Guangcan Chen; Shuhui Liu
Journal:  Front Oncol       Date:  2020-05-14       Impact factor: 6.244

6.  β-Sitosterol Alleviates Inflammatory Response via Inhibiting the Activation of ERK/p38 and NF-κB Pathways in LPS-Exposed BV2 Cells.

Authors:  Yanan Sun; Ling Gao; Wei Hou; Jie Wu
Journal:  Biomed Res Int       Date:  2020-05-27       Impact factor: 3.411

7.  Casticin protected against neuronal injury and inhibited the TLR4/NF-κB pathway after middle cerebral artery occlusion in rats.

Authors:  Dan Huang; Jiafan Zhou; Wenning Li; Li Zhang; Xiaomeng Wang; Qiang Liu
Journal:  Pharmacol Res Perspect       Date:  2021-04

8.  Immunomodulatory effect of dimethyloxallyl glycine/nanosilicates-loaded fibrous structure on periodontal bone remodeling.

Authors:  Zi-Qi Liu; Ling-Ling Shang; Shao-Hua Ge
Journal:  J Dent Sci       Date:  2020-11-26       Impact factor: 2.080

9.  Chlojaponilactone B Attenuates Lipopolysaccharide-Induced Inflammatory Responses by Suppressing TLR4-Mediated ROS Generation and NF-κB Signaling Pathway.

Authors:  Shaoxia Ye; Qiyao Zheng; Yang Zhou; Bai Bai; Depo Yang; Zhimin Zhao
Journal:  Molecules       Date:  2019-10-16       Impact factor: 4.411

10.  Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner.

Authors:  Xiao-Ting Huang; Wei Liu; Yong Zhou; Cai-Xia Hao; Yan Zhou; Chen-Yu Zhang; Chen-Chen Sun; Zi-Qiang Luo; Si-Yuan Tang
Journal:  Int J Mol Med       Date:  2019-10-29       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.